Where does Freda Lewis-Hall work?

Freda Lewis-Hall is Venture Partner at Catalio Capital Management, LP.

What does Freda Lewis-Hall invest in?

Freda Lewis-Hall invests in Biotech, Digital Health.

What check size does Freda Lewis-Hall write?

Freda Lewis-Hall typically writes checks of $100K – $5M.

What boards does Freda Lewis-Hall sit on?

Freda Lewis-Hall holds tracked board seats at 1LifeHealthcare, Inc., Exact Sciences, Milliken and Company, SpringWorks Therapeutics.

Where did Freda Lewis-Hall go to school?

Freda Lewis-Hall studied at Howard University College of Medicine (MD); The Johns Hopkins University; Annapolis Senior High School.

Freda Lewis-Hall

Investor

Venture Partner at Catalio Capital Management, LP

New York, New York

Writes $100K – $5M checks · typically $1.5M

Find your path to Freda

38 people in our graph share verified history with Freda — schools, employers, funds. One of them is your warm intro.

Stella RobertsonunlockedFreda: together at The Johns Hopkins University (1973–1976)

×10Freda: together at Catalio Capital Management, LP

Freda: together at Howard University College of Medicine

About

Freda Lewis-Hall previously served as Chief Medical Officer and Executive Vice President at Pfizer and at Vertex Pharmaceuticals, and as Senior Vice President at Bristol-Myers Squibb. She holds a BA from Johns Hopkins University and an MD from Howard University College of Medicine, and her expertise spans drug development and delivery, bio-pharmaceutical management, health disparities, and psychiatry.

Invests in

BiotechDigital Health

Experience

PfizerExecutive Vice President2020
PfizerChief Patient Officer2019 — 2020
PfizerExecutive Vice President and Chief Medical Officer2009 — 2020
Vertex PharmaceuticalsExecutive Vice President Medicines Development Group and Chief Medical Officer2008 — 2009
Bristol-Myers SquibbSenior Vice President, US Medical Affairs2003 — 2008
Eli LillyProduct Team Leader1998 — 2002

Skills & more

Executive Leadership5BiopharmaBoard GovernanceOncology99Medicine99Clinical Development99Cardiology31Medical Devices4Clinical Trials99Medical Affairs99Managed Care27Product Launch25

+12 more

Clinical ResearchDrug DevelopmentDiabetesRheumatologyNeuroscienceBiotechnologyPharmaceuticsNeurologyMedia & Public Speaking & Strategic AdvisoryPatient Engagement StrategyGlobal Health EquityPharmaceutical Industry

From Freda's professional profile.

Investments

Board seats

1LifeHealthcare, Inc.Exact SciencesMilliken and CompanySpringWorks Therapeutics

Per the firm's website.

Colleagues at Catalio Capital Management, LP

Adam Riess

Venture Partner at Catalio Capital Management, LP

Alan Ashworth

Venture Partner at Catalio Capital Management, LP

Christine E. 'Kricket' Seidman

Venture Partner at Catalio Capital Management, LP

Dan Littman

Venture Partner at Catalio Capital Management, LP

David Sinclair

Venture Partner at Catalio Capital Management, LP

Diamantis Xylas

Analyst at Catalio Capital Management, LP

Frances H. Arnold

Venture Partner at Catalio Capital Management, LP

George C. Petrocheilos

Co-Founder and Managing Partner at Catalio Capital Management, LP

Network4

Adam Riess

Venture Partner at Catalio Capital Management, LP

Alan Ashworth

Venture Partner at Catalio Capital Management, LP

Christine E. 'Kricket' Seidman

Venture Partner at Catalio Capital Management, LP

Dan Littman

Venture Partner at Catalio Capital Management, LP

Investors connected to Freda in public investor directories — a warm-intro map.

Frequently asked questions

Who is Freda Lewis-Hall?: Freda Lewis-Hall previously served as Chief Medical Officer and Executive Vice President at Pfizer and at Vertex Pharmaceuticals, and as Senior Vice President at Bristol-Myers Squibb. She holds a BA from Johns Hopkins University and an MD from Howard University College of Medicine, and her expertise spans drug development and delivery, bio-pharmaceutical management, health disparities, and psychiatry.
Where does Freda Lewis-Hall work?: Freda Lewis-Hall is Venture Partner at Catalio Capital Management, LP.
What does Freda Lewis-Hall invest in?: Freda Lewis-Hall invests in Biotech, Digital Health.
What check size does Freda Lewis-Hall write?: Freda Lewis-Hall typically writes checks of $100K – $5M.
What boards does Freda Lewis-Hall sit on?: Freda Lewis-Hall holds tracked board seats at 1LifeHealthcare, Inc., Exact Sciences, Milliken and Company, SpringWorks Therapeutics.
Where did Freda Lewis-Hall go to school?: Freda Lewis-Hall studied at Howard University College of Medicine (MD); The Johns Hopkins University; Annapolis Senior High School.

Same school

Also attended Howard University College of Medicine1

Dr. Derek RobinsonSenior Advisor at PACE Healthcare Capital

Also attended The Johns Hopkins University442

Dave JohnsonCo-founder & CEO of Dash Bio Nicole GaudelliEntrepreneur in Residence at GV (Google Ventures)Wes NicholsPartner at March Capital Partners Demi ObayomiPrincipal at Sapphire Ventures Jun JeonInvestor at Khosla Ventures Nicole FraenkelInvestor at Khosla Ventures

+ 436 more

Shared employers

Also worked at Pfizer229

Jigar RaythathaInvestor at Third Rock Ventures Abbie CelnikerInvestor at Third Rock Ventures Erin MooreInvestor at Third Rock Ventures Jeb KeiperInvestor at Third Rock Ventures Richard ChesworthInvestor at Third Rock Ventures Michael TaylorOperating Partner at Mission Biocapital

+ 223 more

Also worked at Vertex Pharmaceuticals29

Bruce SachsInvestor at CRV (Charles River Ventures)Jesper GromadaInvestor at Third Rock Ventures Stephen ChambersGeneral Partner at SOSV Alexandra CantleyManaging Partner at Polaris Partners Roger TungVenture Partner at Longwood Fund Lloyd CarneyStrategic Advisor at Vertical Venture Partners

+ 23 more

Also worked at Bristol-Myers Squibb85

Scott BillerInvestor at GV (Google Ventures)Avantika DaingFounding Partner at Plum Alley Investments Jake BauerVenture Partner at ARCH Venture Partners Scott DonohueSenior Director, Market Access at Deerfield Management Company Mellissa GraySenior Scientist, Protein Sciences at Deerfield Management Company Beth SeidenbergFounding Managing Director at Westlake Village BioPartners

+ 79 more

Also worked at Eli Lilly120

David MollerInvestor at Third Rock Ventures Jesper GromadaInvestor at Third Rock Ventures Mark LevinRetired Founding Partner at Third Rock Ventures Natalie FurneyGlobal General Counsel at Takeda Ventures Rhonda PachecoPresident, U.S. Business Unit and U.S. Country Head at Takeda Ventures Carlos PayaVenture Partner at Ysios Capital

+ 114 more